Iovance Biotherapeutics Inc. Common Stock vs Super Group (SGHC) Limited Ordinary Shares — how do they compare? Iovance Biotherapeutics Inc. Common Stock trades at $14.68 (market cap $6.04B), while Super Group (SGHC) Limited Ordinary Shares trades at $11.34 (market cap $5.86B). The key difference: Iovance Biotherapeutics Inc. Common Stock and Super Group (SGHC) Limited Ordinary Shares are close in size by market cap, and Super Group (SGHC) Limited Ordinary Shares pays a 1.73% dividend while Iovance Biotherapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Iovance Biotherapeutics Inc. Common Stock for 0 Days and Super Group (SGHC) Limited Ordinary Shares for 1 Days on average.
| IOVA | SGHC | |
|---|---|---|
Market Cap | $6.04B | $5.86B |
Volume | 14,805,993 | 1,905,788 |
Sector | Health | Consumer Cyclical |
52-Week High | $14.82 | $15.59 |
52-Week Low | $1.81 | $8.52 |
Typical Hold Time | 0 Days | 1 Days |
Enterprise Value | $5.97B | $5.41B |
Dividend Yield | — | 1.73% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Iovance Biotherapeutics develops cell therapies for cancer. Its approach uses tumor-infiltrating lymphocytes, or TIL, to target solid tumors.
Read more on IOVA →Super Group (SGHC) Limited is a holding company for online sports betting and gaming businesses, operating the Betway sports betting brand and the Spin multi-brand online casino portfolio across markets in Europe, the Americas, and Africa.
Read more on SGHC →